Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Varian Medical Systems Inc (NYSE:VAR)

During the Trading Day
90.39 +1.06 / +1.19%
As of 4:04pm ET
Day’s Change
During After-Hours   Switch to standard view »
85.50 -4.89 / -5.41%
 
Volume: 9.9K
SECTOR
Health Technology
INDUSTRY
Medical Specialties
MARKET CAP
$8.9B

Company Description

Varian Medical Systems, Inc. engages in the manufacture of medical devices and software for treating cancer and other medical condition. It operates through the following segments: Oncology Systems, Imaging Components, and Other. The Oncology Systems segment designs, manufactures, sells, and services hardware and software products for treating cancer with conventional radiotherapy including IMRT, IGRT and volumetric modulated arc therapy, stereotactic body radiotherapy, stereotactic radiotherapy, stereotactic radiosurgery and brachytherapy. The Imaging Components segment designs, manufactures, sells, and services X-ray imaging components for use in different applications, including radiographic or fluoroscopic imaging, mammography, specific procedures, computed tomography, and industrial applications. The Other segment comprises of Varian Particle Therapy, which manufactures and sells products and systems for delivering proton therapy; and operations of the Ginzton Technology Center, which is the firm's scientific research facility. The company was founded by William Hansen, Edward Ginzton, Russell Varian, and Sigurd Varian in 1948 and is headquartered in Palo Alto, CA.

Contact Information

Varian Medical Systems, Inc.
3100 Hansen Way
Palo Alto California 94304-1038
P:(650) 493-4000
Investor Relations:
(650) 424-5782

Employees

Shareholders

Other institutional48.18%
Mutual fund holders48.12%
Individual stakeholders0.50%

Top Executives

Dow R. WilsonPresident, Chief Executive Officer & Director
Elisha W. FinneyChief Financial Officer & Executive Vice President
Jessica L. DenecourChief Information Officer & Senior Vice President
Kolleen T. KennedyPresident-Oncology Systems & Senior Vice President
John W. KuoSecretary, Senior Vice President & General Counsel